Skip to content
California Healthline California Healthline California Healthline
  • Republish Our Content
  • Email Sign Up
  • Contact Us
  • Connect With Us:
  • Contact
  • Twitter
  • Facebook
  • RSS
  • Daily Edition
  • Special Reports
    • Homeless Crisis
    • Medi-Cal Makeover
    • Industry Influence
    • Public Health Watch
  • Faces of Medi-Cal
  • Noticias En Español
  • More Topics
    • Aging
    • Asking Never Hurts
    • Audio Report
    • Covid
    • Health Industry
    • Insurance
    • Medi-Cal
    • Medicare
    • Mental Health
    • Spotlight

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 131-140 of 171 results for "Emmarie Huetteman"

Sort by

La revancha del debate Biden-Harris destaca diferencias en los planes de salud

By Emmarie Huetteman July 31, 2019

Hay casi tantas versiones de “Medicare para Todos” como candidatos demócratas, y cada uno piensa que su plan es el camino para asegurar a todos los estadounidenses.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

In A Messy Democratic Presidential Debate, Facts About Medicare For All Get Tossed About

By Emmarie Huetteman July 30, 2019

Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Democrats Favor Building On ACA Over ‘Medicare For All’

By Emmarie Huetteman July 30, 2019

Asked to choose between building on the Affordable Care Act and replacing it with a national Medicare for All plan, 55% of Democrats and Democratic-leaning independents said they would expand the existing law, according to a Kaiser Family Foundation poll released Tuesday.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices

By Emmarie Huetteman July 25, 2019

Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

By Emmarie Huetteman July 24, 2019

Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers

By Emmarie Huetteman June 28, 2019

A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Universal Health Care For New Yorkers? Not Exactly

By Emmarie Huetteman June 27, 2019

Despite what New York Mayor Bill de Blasio claimed during the first night of the presidential debates, universal health care in the Big Apple is still in the seeding stage.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Watch: Big Week For Drug Pricing Debate Featured On C-SPAN

March 1, 2019

KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Trump Administration Rule Would Undo Health Care Protections For LGBTQ Patients

By Emmarie Huetteman June 13, 2019

Supporters of the rule say it would strengthen health care professionals’ freedom of conscience, but opponents say it “empowers bad actors to be bad actors.”

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

By Emmarie Huetteman June 12, 2019

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next

From The California Health Care Foundation

Insurance Data Health Insurers Enrollment Almanac — 2025 Edition

The latest data shows that California health insurers covered 36.2 million people. See a breakdown of enrollment by regulator, market, and insurer, and access historical data.

The Latest on CalAIM Reforms

CalAIM has the potential to improve health outcomes for millions of people enrolled in Medi-Cal. Track the latest developments and insights on this multi-year reform effort.

Behavioral Health California's Behavioral Health Data Landscape

As the state embarks on a significant overhaul, this report captures the current state of behavioral health data collection. See how it currently measures quality and outcomes, as well as future directions for the system.

California Healthline

© California Healthline 1998-2025. All Rights Reserved.

California Healthline is a service of the California Health Care Foundation produced by KFF Health News, an editorially independent program of the KFF.

  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • Twitter
  • Facebook
  • RSS

Powered by WordPress VIP